Genetic Polymorphisms, Plasma Levels of Lipoprotein (A) and its Possible Links with Degenerative Aortic Stenosis

1. Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC), European Association for Cardio-Thoracic Surgery (EACTS), Vahanian A, Alfieri O, Andreotti F, Antunes MJ, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012;33( 19):2451-96.Search in Google Scholar

2. Kamenova Z, Grigorov M, Ingeliev M, Petrova G, Pesheva B. [Correlation between degenerative aortic stenosis and coronary disease], Medlnfo. 2012;4(9):22-6. Bulgarian.Search in Google Scholar

3. Rosenhek R, Binder T, Porenta G, Lang I, Christ G, Schemper M, et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med. 2000;343(9):611-7.10.1056/NEJM200008313430903Search in Google Scholar

4. Trayanov I. [Aortic stenosis and aortic regurgitation], Cardio D. 2007;4(2):34-41. Bulgarian.Search in Google Scholar

5. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med. 1999;341(3): 142-7.10.1056/NEJM199907153410302Search in Google Scholar

6. Cosmi JE, Kort S, Tunick PA, Rosenzweig BP, Freedberg RS, Katz ES, et al. The risk of the development of aortic stenosis in patients with “benign” aortic valve thickening. Arch Intern Med. 2002; 162(20):2345-7.10.1001/archinte.162.20.234512418948Search in Google Scholar

7. Carabello B, Paulus W. Aortic stenosis. Lancet. 2009;373(9667):956-66.10.1016/S0140-6736(09)60211-7Search in Google Scholar

8. Koleva K, Zlatareva N, Gudev A. [A new look at degenerative aortic stenosis], MP - SSZ. 2007;38(4): 14-9. Bulgarian.Search in Google Scholar

9. Hughes B, Chhoud G, Mehta JL. Aortic stenosis: is it simply a degenerative process or an active atherosclerotic process? Clin Cardiol. 2005;28(3):111-4.10.1002/clc.4960280303665434215813615Search in Google Scholar

10. Nordestgaard BG, Chapman MJ, Ray K, Boren J, Andreotti F, Watts GF, et al. Lipoprotein (a) as| a cardiovascular risk factor: current status. Eur Heart J. 2010;31(23):2844-53.10.1093/eurheartj/ehq386329520120965889Search in Google Scholar

11. Clarke R, Peden F, Hopewell C, Kyriakou T, Goel A, Heath SC, et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med. 2009;361 (26):2518-28.10.1056/NEJMoa090260420032323Search in Google Scholar

12. Bozbas H, Yildirir A, Atar I, Pirat B, Eroglu S, Aydinalp A, et al. Effects of serum levels of novel atherosclerotic risk factors on aortic valve calcification. J Heart Valve Dis. 2007;16(4):387-93.Search in Google Scholar

13. Parolari A, Loardi C, Mussoni L, Cavallotti L, Camera M, Biglioli P, et al. Nonrheumatic calcific aortic stenosis: an overview from basic science to pharmacological prevention. Eur J Cardiothorac Surg. 2009;35(3):493-504.10.1016/j.ejcts.2008.11.03319162497Search in Google Scholar

14. De Vecchis R, Di Biase G, Esposito C, Ciccarelli A, Cioppa C, Giasi A, et al. Statin use for nonrheumatic calcific aortic valve stenosis: a review with meta-analysis. J Cardiovasc Med. 2013;14(8):559-67.he development of aortic stenosis in patients with “benign” aortic valve thickening. Arch Intern Med. 2002;162(20):2345-7.10.1001/archinte.162.20.2345Search in Google Scholar

15. Thanassoulis G, Campbell CY, Owens DS, Smith JG, Smith AV, Peloso GM, et al. Genetic associations with valvular calcification and aortic stenosis. N Engl J Med. 2013;368:503-12.10.1056/NEJMoa1109034376662723388002Search in Google Scholar

16. Psaty BM, O’Donnell CJ, Gudnason V, Lunetta KL, Folsom AR, Rotter JI, et al. Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: Design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circ Cardiovasc Genet. 2009;2(l):73-80.10.1161/CIRCGENETICS.108.829747Search in Google Scholar

17. Gotoh T, Kuroda T, Yamasawa M, Nishinaga M, Mitsuhashi T, Seino Y, et al. Correlation between lipoprotein(a) and aortic valve sclerosis assessed by echocardiography (the JMS Cardiac Echo and Cohort Study). Am J Cardiol. 1995;76(12):928-32.10.1016/S0002-9149(99)80263-XSearch in Google Scholar

18. Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol. 1997;29(3):630-4.10.1016/S0735-1097(96)00563-3Search in Google Scholar

19. O’Brien KD, Reichenbach DD, Marcovina SM, Kuusisto J, Alpers CE, Otto CM. Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis. Arterioscler Thromb Vase Biol. 1996; 16(4):523-32.10.1161/01.ATV.16.4.523Search in Google Scholar

20. Gladera CA, Birgander LS, Soderberg S , Ildgruben HP, Saikku P, Waldenstrom A, et al. Lipoprotein(a), Chlamydia pneumoniae, leptin and tissue plasminogen activator as risk markers for valvular aortic stenosis. Eur Heart J. 2003;24:198-08.10.1016/S0195-668X(02)00385-8Search in Google Scholar

21. Thanassoulis G, Massaro JM, Cury R, Manders E, Benjamin EJ, Vasan RS, et al. Associations of long-term and early adult atherosclerosis risk factors with aortic and mitral valve calcium. J Am Coll Cardiol. 2010;55(22):2491 -8.10.1016/j.jacc.2010.03.019304224920510217Search in Google Scholar

22. Kutikhin AG, Yuzhalin AE, Brusina EB, Ponasenko AV, Golovkin AS, Barbarash OL. Genetic predisposition to calcific aortic stenosis and mitral annular calcification. Mol Biol Rep. 2014;41(9):5645-63.10.1007/s11033-014-3434-924903972Search in Google Scholar

23. Ortlepp JR, Schmitz F, Mevissen V, Weiss S, Huster J, Dronskowski R, et al. The amount of calcium-deficient hexagonal hydroxyapatite in aortic valves is influenced by gender and associated with genetic polymorphisms in patients with severe calcific aortic stenosis. Eur Heart J. 2004;25(6):514-22.10.1016/j.ehj.2003.09.00615039132Search in Google Scholar

24. Gaudreault N, Ducharme V, Lamontagne M, Guauque-Olarte S, Mathieu P, Pibarot P, et al. Replication of genetic association studies in aortic stenosis in adults. Am J Cardiol. 2011;108(9):1305-10.10.1016/j.amjcard.2011.06.05021855833Search in Google Scholar

25. Owens DS, Katz R, Johnson E, Shavelle DM, Probstfield JL, Takasu J, et al. Interaction of age with lipoproteins as predictors of aortic valve calcification in the multi-ethnic study of atherosclerosis. Arch Intern Med. 2008; 168(11): 1200-7.10.1001/archinte.168.11.1200444101318541828Search in Google Scholar

26. Kronenberg F, Utermann G. Lipoprotein(a): Resurrected by genetics. J Intern Med. 2013;273( l):6-30.10.1111/j.1365-2796.2012.02592.xSearch in Google Scholar

27. Koschinsky L. Novel insights into Lp(a) physiology and pathogenicity: more questions than answers? Cardiovasc Hematol Disord Drug Targets. 2006;6(4):267-78.10.2174/187152906779010764Search in Google Scholar

28. Kamstrup R, Tybjserg-llansen A, Nordestgaard G. Lipoprotein(a) and risk of myocardial infarction-genetic epidemiologic evidence of causality. Scand J Clin Lab Invest. 2011 ;71(2):87-93.10.3109/00365513.2010.550311Search in Google Scholar

29. Berg K. A new serum type system in man-the Lp system. Acta Pathol Microbiol Scand. 1963;59:369-82.10.1111/j.1699-0463.1963.tb01808.xSearch in Google Scholar

30. McLean JW, Tomlinson JE, Kuang WJ, Eaton DL, Chen EY, Fless GM, et al. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature. 1987;330(6144): 132-7.10.1038/330132a0Search in Google Scholar

31. Utermann G, Menzel HJ, Kraft HG, Duba HC, Kemmler HG, Seitz C. Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest. 1987;80(2):458-65.10.1172/JCI113093Search in Google Scholar

32. Patthy L, Trexler M, Banyai L, Varadi A, Vali Z. Kringles: modules specialized for protein binding. Homology of the gelatin-binding region of fibronectin with the kringle structures of proteases. FEBS Lett. 1984; 171 (1): 131 -6.10.1016/0014-5793(84)80473-1Search in Google Scholar

33. Atkinson RA, Williams RJ. Solution structure of the kringle 4 domain from human plasminogen by 1H nuclear magnetic resonance spectroscopy and distance geometry. J Mol Biol. 1990;212(3):541 -52.10.1016/0022-2836(90)90330-OSearch in Google Scholar

34. Knight BL, Perombelon YF, Soutar AK, Wade DR Seed M. Catabolism of lipoprotein(a) in familial hypercholesterolaemic subjects. Atherosclerosis. 1991 ;87(2-3):227-37.10.1016/0021-9150(91)90025-XSearch in Google Scholar

35. Albers JJ, Koschinsky ML, Marcovina SM. Evidence mounts for a role of the kidney in lipoprotein(a) catabolism. Kidney Int. 2007 ;71 (10):961 -2.10.1038/sj.ki.500224017495935Search in Google Scholar

36. Rath M, Pauling L. A unified theory of human cardiovascular disease leading the way to the abolition of this disease as a cause for human mortality. J Orthomol Med. 1992;7( 1 ):5-15.Search in Google Scholar

37. Sotiriou SN, Orlova VV, Al-Fakhri N, lhanus E, Economopoulou M, Isermann B, et al. Lipoprotein(a) in atherosclerotic plaques recruits inflammatory cells through interaction with Mac-1 integrin. FASEB J. 2006;20(3):559-61. 10.1096/fj.05-4857fje16403785Search in Google Scholar